This section has a list of generic name(s) and the several brand name(s) of the drugs used for the treatment of
Recent Advances in the Management of Breast Cancer (Breast Cancer Management: Recent Advances). Its purpose is to provide doctors and consumers a ready reckoner to find the relevant drugs.
The information helps you learn more about the generic drug, including its brand name(s), price, dosage, side effects, adverse events, how to take and appropriate times to take it by simply click on the drugs. Plus there are FAQs too about each drug.
Advertisement
Brand Names and Generic Names of Drugs for Treatment of Breast Cancer Management: Advances
Abemaciclib is used alone or with other drugs such as fulvestrant or anastrozole for treating women with advanced breast cancer or breast cancer that has spread to other parts of the body and hormone receptor-positive breast cancer.
Ado-trastuzumab Emtansine is used to treat HER2-positive metastatic breast cancer, a specific type of breast cancer that has moved to other parts of the body.
Advertisement
Anastrozole is a non-steroidal inhibitor used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause.
Trade Names :
More...
Bevacizumab is used to treat certain types of advanced lung cancer.
Capecitabine is an antimetabolite, prescribed for breast cancer and colorectal cancer.
Trade Names :
More...
Advertisement
Cyclophosphamide is an antineoplastic agent, prescribed for many types of cancers like lymphatic cancer, cancer of white blood cells and plasma cells, etc,.
Trade Names :
More...
Docetaxel is an anti-cancer agent, mainly used for the treatment of breast, ovarian, gastric cancer, head and neck cancer, prostate cancer and non-small cell lung cancer either alone or with other medications.
Trade Names :
More...
Doxorubicin is a cytotoxic anthracycline antibiotic, prescribed for treating various types of cancer.
Trade Names :
More...
Eribulin Mesylate is an anticancer agent, prescribed for breast cancer.
Exemestane is an aromatase inhibitor, prescribed for advanced breast cancer in postmenopausal women who are no longer responsive to anti-estrogen therapy.
Trade Names :
Fluorouracil is an antimetabolite, prescribed for certain types of cancer such as colon, rectal, breast, stomach and pancreatic cancer.
Trade Names :
More...
Fluoxymesterone is an androgenic hormone, prescribed for male hypogonadism, delayed puberty in males and for breast cancer treatment in women.
Fulvestrant is an estrogen receptor antagonist, prescribed for advanced breast cancer in postmenopausal women who have already been treated with other medications.
Gemcitabine is a nucleoside analog used in chemotherapy for treating certain types of cancer (like lung cancer, pancreatic cancer, breast cancer, ovarian cancer).
Trade Names :
More...
Ixabepilone is prescribed for breast cancer either alone or in combination with capecitabine.
Lapatinib is a protein-tyrosine kinase inhibitor, prescribed for metastatic breast cancer with other medications.
Letrozole is an aromatase inhibitor, prescribed for breast cancer either alone or in combination with other medications.
Trade Names :
More...
Methotrexate is an antimetabolite, curative in choriocarcinoma (cancer of the tissue that normally would develop into placenta).
Trade Names :
More...
Neratinib is prescribed as an adjuvant therapy to treat adult patients with an early stage HER2 - positive breast cancer who have been already treated with trastuzumab therapy at least for a year.
Paclitaxel is a chemotherapy agent, prescribed for ovarian and breast cancer.
Trade Names :
More...
Palbociclib is a kinase inhibitor which is prescribed along with letrazole (an aromatase inhibitor) for the treatment of certain type of hormone receptor positive breast cancer (estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer) in postmenopausal women that is in an advanced stage or has spread to other parts of the body.
Ribociclib belongs to a class of medications called kinase inhibitors; it inhibits the cyclin-dependent kinase (CDK) 4 and 6.
Tamoxifen is an antiestrogen, prescribed for breast cancer.
Trade Names :
More...
Trastuzumab is a monoclonal antibody, prescribed for breast cancer either alone or in combination with other medications.
Trade Names :
Related Drugs by Medical Condition
Recommended Reading
Did u know that simple changes in lifestyle could lower your cancer risks? Find out how!
Breast cancer is a kind of cancer that develops from breast cells and affects mainly women worldwide and sometimes men. Read Medindia's top facts on Breast cancer.
Different stages of breast development in women and an in-depth look at the breast/bust and its structure.
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth ...
Slides and animation of Breast Self Examination for early detection of breast cancer lumps in women
Breast lumps must never be neglected but instead be subjected to medical examination to rule out cancer.
Most breast lumps are caused by hormonal changes in a woman and may not be cancerous. Common causes of breast lumps include fibroadenosis, breast cancer, breast cyst.
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
Breast biopsy involves removing a sample of breast tissue to determine whether it is cancerous or benign.
The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.
Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.
Triple-negative breast cancers are ER negative, PR negative, and lack overexpression of HER-2. They are difficult to treat and are very aggressive.
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.
